Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-22-000805

Chief Financial Officer acquired 19,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Silberman David Chief Financial Officer 2022-01-03 Grant or award +19,000 69,000 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Silberman David Chief Financial Officer 2022-01-03 Grant or award · Stock Option (right to buy) +32,000 32,000 D: show line 2 in the form
Loading xslF345X03/ownership.xml…